Status:
NOT_YET_RECRUITING
The Effects of Psilocybin on Shared Experience in Film Processing
Lead Sponsor:
Western University, Canada
Conditions:
Disorders of Consciousness
Psychedelic Experiences
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn whether certain methods of detecting awareness in vegetative or minimally conscious patients (using neuroimaging) are sensitive to the effects of psilocybin...
Eligibility Criteria
Inclusion
- Participants must:
- Have access to an internet connection
- Be in good general health
- Be 19 years of age, or older
- Be willing to follow the study protocol
Exclusion
- The following people will be excluded from the study. Those who:
- Are unable to read English
- Have high blood pressure
- Are pregnant (determined by a urine pregnancy test at in-person screening)
- Are not using effective methods of contraception with their partner(s) (e.g. oral contraceptive pill, injection, implant, patch, vaginal ring, intrauterine coil, intrauterine device, tubal ligation, or barrier method)
- Are taking chronic administration of tricyclic antidepressants and/or lithium
- Are taking acute administration of serotonin reuptake inhibitors
- Are currently using the antipsychotic medication haloperidol
- Are currently using monoamine oxidase inhibitors
- Have any current or past history of meeting the Diagnostic and Statistical Manual of Mental Illnesses (DSM-V) criteria for schizophrenia, bipolar I, bipolar II, or psychotic symptoms
- Have any first or second-degree relatives with history of above disorders/symptoms
- Have any other diagnosed and/or extreme psychiatric disorders, such as anxiety, depression, post-traumatic stress disorder (PTSD), addiction, obsessive-compulsive disorder (OCD), etc.
- Have any history of suicidal behaviour or current/recent suicidal ideation (determined by the Columbia-Suicide Severity Rating Scale \[C-SSRS\] at in-person screening)
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06529939
Start Date
November 1 2024
End Date
September 1 2025
Last Update
September 27 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.